翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688626 翔宇医疗

已收盘 03-23 15:00:00

{"stockData":{"symbol":"688626","market":"SH","secType":"STK","nameCN":"翔宇医疗","latestPrice":53.61,"timestamp":1774249200000,"preClose":56.78,"halted":0,"volume":2585226,"delay":0,"changeRate":-0.0558,"floatShares":160000000,"shares":160000000,"eps":0.4595,"marketStatus":"已收盘","change":-3.17,"latestTime":"03-23 15:00:00","open":55,"high":56.36,"low":53.2,"amount":142000000,"amplitude":0.0557,"askPrice":53.75,"askSize":2,"bidPrice":53.61,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.4595,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774315800000},"marketStatusCode":5,"adr":0,"adjPreClose":56.78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1774229400000,1774236600000],[1774242000000,1774249200000]],"highLimit":62.46,"lowLimit":51.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":160000000,"isCdr":false,"pbRate":4.23,"roa":"--","peRate":116.670294,"roe":"2.09%","epsLYR":0.66,"committee":0.197674,"marketValue":8578000000,"turnoverRate":0.0162,"status":1,"afterMarket":{"amount":0,"volume":0,"close":53.61,"buyVolume":755,"sellVolume":0,"time":1774251237558,"indexStatus":"已收盘 03-23 15:30:00","preClose":56.78},"floatMarketCap":8578000000},"requestUrl":"/m/hq/s/688626","defaultTab":"news","newsList":[{"id":"2619458178","title":"中银国际：全球首款侵入式脑机产品获批 行业迈入商业化验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2619458178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619458178?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:05","pubTimestamp":1773648327,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中银国际发布研报称，近日，国家药监局批准博睿康植入式脑机接口手部运动功能代偿系统创新产品注册申请，实现脑机接口全球首发上市，标志中国脑机接口产业从“技术验证”迈向“商业化落地”。投资建议随着全球首款侵入式产品获批上市，国内脑机接口产业已进入商业化验证期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中银国际：全球首款侵入式脑机产品获批 行业迈入商业化验证期","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300753","002173","688273","BK0077","301293","688580","301087","BK0114","BK0251","688626","BK0096","BK0236","301363"],"gpt_icon":0},{"id":"2619178328","title":"每周股票复盘：翔宇医疗（688626）现多笔折价大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2619178328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619178328?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:48","pubTimestamp":1773514090,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，翔宇医疗报收于72.28元，较上周的63.98元上涨12.97%。本周，翔宇医疗3月13日盘中最高价报76.99元。来自公司公告汇总：翔宇医疗股东及其一致行动人合计持股比例由65.62%减少至65.00%，触及5%整数倍刻度线。交易信息汇总3月10日翔宇医疗现5笔折价11.27%的大宗交易，合计成交1816.56万元。本次权益变动后，信息披露义务人及其一致行动人合计持股比例由65.62%降至65.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2618944772","title":"3月11日翔宇医疗发布公告，股东减持99.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618944772","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618944772?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:01","pubTimestamp":1773230496,"startTime":"0","endTime":"0","summary":"证券之星消息，3月11日翔宇医疗发布公告《翔宇医疗:翔宇医疗简式权益变动报告书》，其股东安阳启旭贸易咨询服务中心(有限合伙)于2026年3月6日至2026年3月11日间合计减持99.95万股，占公司目前总股本的0.6247%，变动期间该股股价上涨7.84%，截止3月11日收盘报67.92元。股东增减持详情见下表：根据翔宇医疗2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100035568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2618935818","title":"3月10日翔宇医疗现5笔折价11.27%的大宗交易 合计成交1816.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618935818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618935818?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:20","pubTimestamp":1773134453,"startTime":"0","endTime":"0","summary":"证券之星消息，3月10日翔宇医疗发生大宗交易，交易数据如下：近三个月该股共发生62笔大宗交易，合计成交3.2万手，折价成交62笔。该股近期无解禁股上市。截至2026年3月10日收盘，翔宇医疗(688626)报收于65.33元，上涨1.43%，换手率1.62%，成交量2.59万手，成交额1.68亿元。该股近半年内有股东持股变动，合计净减持84.8万股，股东增减持明细如下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000026848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2617668273","title":"每周股票复盘：翔宇医疗（688626）现多笔折价大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2617668273","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617668273?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:23","pubTimestamp":1772907790,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，翔宇医疗报收于63.98元，较上周的67.37元下跌5.03%。本周，翔宇医疗3月2日盘中最高价报68.66元。交易信息汇总3月6日翔宇医疗发生6笔折价10.43%的大宗交易，合计成交1299.8万元。股本股东变化3月5日，翔宇医疗股东安阳启旭贸易咨询服务中心减持84.8万股，占公司总股本的0.53%，期间股价上涨2.22%，收盘报62.98元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2617689845","title":"3月6日翔宇医疗现6笔折价10.43%的大宗交易 合计成交1299.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617689845","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617689845?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:35","pubTimestamp":1772789723,"startTime":"0","endTime":"0","summary":"证券之星消息，3月6日翔宇医疗发生大宗交易，交易数据如下：    近三个月该股共发生51笔大宗交易，合计成交2.68万手，折价成交51笔。该股近期无解禁股上市。截至2026年3月6日收盘，翔宇医疗(688626)报收于63.98元，上涨1.59%，换手率1.99%，成交量3.19万手，成交额2.07亿元。该股近半年内有股东持股变动，合计净减持314.67万股，股东增减持明细如下表：    该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/06/20260306946007.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/06/20260306946007.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260306/32050332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2617118517","title":"3月5日翔宇医疗现16笔折价10.97%的大宗交易 合计成交4754.73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617118517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617118517?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:21","pubTimestamp":1772702505,"startTime":"0","endTime":"0","summary":"证券之星消息，3月5日翔宇医疗发生大宗交易，交易数据如下：近三个月该股共发生45笔大宗交易，合计成交2.45万手，折价成交45笔。该股近期无解禁股上市。截至2026年3月5日收盘，翔宇医疗(688626)报收于62.98元，上涨2.22%，换手率2.34%，成交量3.75万手，成交额2.38亿元。该股近半年内有股东持股变动，合计净减持229.87万股，股东增减持明细如下表：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500028014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2616533249","title":"3月4日翔宇医疗现26笔折价10.71%的大宗交易 合计成交8283.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616533249?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:20","pubTimestamp":1772616043,"startTime":"0","endTime":"0","summary":"证券之星消息，3月4日翔宇医疗发生大宗交易，交易数据如下：近三个月该股共发生29笔大宗交易，合计成交1.6万手，折价成交29笔。该股近期无解禁股上市。截至2026年3月4日收盘，翔宇医疗(688626)报收于61.61元，下跌0.16%，换手率1.34%，成交量2.15万手，成交额1.33亿元。该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400030217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2616363856","title":"股市必读：3月2日翔宇医疗现601.44万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2616363856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616363856?lang=zh_cn&edition=full","pubTime":"2026-03-03 03:06","pubTimestamp":1772478374,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，翔宇医疗报收于67.65元，上涨0.42%，换手率2.17%，成交量3.47万手，成交额2.33亿元。当日关注点来自交易信息汇总：3月2日主力资金净流入71.54万元，占总成交额0.31%。来自交易信息汇总：当日翔宇医疗发生601.44万元大宗交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300002355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2616843166","title":"每周股票复盘：翔宇医疗（688626）2025年净利降23.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843166","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843166?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:04","pubTimestamp":1772301853,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，翔宇医疗报收于67.37元，较上周的68.28元下跌1.33%。本周，翔宇医疗2月24日盘中最高价报68.88元。本周关注点来自业绩披露要点：翔宇医疗2025年归属净利润同比下降23.55%。公司公告汇总河南翔宇医疗设备股份有限公司发布2025年度业绩快报，营业总收入为76,774.74万元，同比增长3.26%；归属于母公司所有者的净利润为7,869.90万元，同比下降23.55%；扣除非经常性损益的净利润为5,895.43万元，同比下降34.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2614526678","title":"翔宇医疗（688626）披露2025年度业绩快报公告，2月27日股价上涨2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614526678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614526678?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:44","pubTimestamp":1772203454,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，翔宇医疗报收于67.37元，较前一交易日上涨2.7%，最新总市值为107.79亿元。近日，河南翔宇医疗设备股份有限公司发布2025年度业绩快报，营业总收入为76,774.74万元，同比增长3.26%；归属于母公司所有者的净利润为7,869.90万元，同比下降23.55%；扣除非经常性损益的净利润为5,895.43万元，同比下降34.48%。报告期末总资产为326,863.19万元，同比增长11.64%；归属于母公司的所有者权益为207,010.39万元，同比增长1.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2603985126","title":"翔宇医疗：“面向难治性抑郁症的闭环经颅刺激系统”项目入围2025年人工智能医疗器械创新任务揭榜挂帅名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2603985126","media":"证券日报 ","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603985126?lang=zh_cn&edition=full","pubTime":"2026-01-15 21:37","pubTimestamp":1768484220,"startTime":"0","endTime":"0","summary":"证券日报网讯 1月15日，翔宇医疗在互动平台回答投资者提问时表示，近日，公司牵头申报的“面向难治性抑郁症的闭环经颅刺激系统”项目成功入围2025年人工智能医疗器械创新任务揭榜挂帅名单。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180317.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1222","09996","159883","BK1583","688626","161631","BK1100","BK0251","09997"],"gpt_icon":0},{"id":"2603862337","title":"【机构调研记录】中邮基金调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603862337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603862337?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435279,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及1月14日披露的机构调研信息，中邮基金近期对1家上市公司进行了调研，相关名单如下：1）翔宇医疗 调研纪要：脑机接口产品覆盖吞咽、运动、认知等康复场景，有望于2026年实现快速商业化落地。中邮基金成立于2006年，截至目前，资产管理规模759.2亿元，排名73/212；资产管理规模719.8亿元，排名59/212；管理公募基金数109只，排名72/212；旗下公募基金经理24人，排名61/212。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500005047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2603362358","title":"【私募调研记录】瑞民投资调研新开普、翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603362358","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603362358?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435272,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息，知名私募瑞民投资近期对2家上市公司进行了调研，相关名单如下：1）新开普 调研纪要：公司与阿里云、支付宝等阿里系平台保持深度协同，阿里作为战略股东提供技术、算力、生态等多维度战略赋能，并于2025年5月29日在河南省人工智能大会上，与阿里云就新开普校园大模型项目完成战略签约。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0231","BK0170","BK0093","BK0091","BK0133","BK0023","BK0251","688626","BK0129","300248"],"gpt_icon":0},{"id":"2603623375","title":"【私募调研记录】景泰利丰调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603623375?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435269,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息，知名私募景泰利丰近期对1家上市公司进行了调研，相关名单如下：1）翔宇医疗 调研纪要：脑机接口产品覆盖吞咽、运动、认知等康复场景，有望于2026年实现快速商业化落地。近20个省市已出台脑机接口相关收费标准，推动临床普及。截止2019年，景泰已为招商银行总行、民生银行、平安保险集团等多家专业金融机构提供股票委外服务超过5年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00494","688626","BK0251"],"gpt_icon":0},{"id":"2603324623","title":"【私募调研记录】明世伙伴基金调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603324623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603324623?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:01","pubTimestamp":1768435268,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息，知名私募明世伙伴基金近期对1家上市公司进行了调研，相关名单如下：1）翔宇医疗 调研纪要：脑机接口产品覆盖吞咽、运动、认知等康复场景，有望于2026年实现快速商业化落地。近20个省市已出台脑机接口相关收费标准，推动临床普及。明世伙伴基金是一家由专业人士发起，并以资深的专业投研团队为核心而创建的私募证券类基金公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2603623326","title":"【私募调研记录】正圆投资调研翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603623326?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:00","pubTimestamp":1768435256,"startTime":"0","endTime":"0","summary":"根据市场公开信息及1月14日披露的机构调研信息，知名私募正圆投资近期对1家上市公司进行了调研，相关名单如下：1）翔宇医疗 调研纪要：脑机接口产品覆盖吞咽、运动、认知等康复场景，有望于2026年实现快速商业化落地。近20个省市已出台脑机接口相关收费标准，推动临床普及。机构简介：深圳正圆投资2015年成立于深圳前海自贸区，并于当年获得私募证券投资基金牌照。正圆拥有专业的投研团队，丰富的投资经验，完善的风险管理制度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026011500005012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2603643704","title":"股市必读：翔宇医疗（688626）1月14日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2603643704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603643704?lang=zh_cn&edition=full","pubTime":"2026-01-15 01:00","pubTimestamp":1768410037,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，翔宇医疗报收于81.5元，下跌6.04%，换手率6.13%，成交量9.81万手，成交额8.14亿元。来自公司公告汇总：股东安阳启旭拟减持不超过480万股，占总股本不超过3%，减持原因为自身资金需求，减持期间为2026年2月4日至5月3日。公司公告汇总翔宇医疗关于股东减持股份计划公告河南翔宇医疗设备股份有限公司股东安阳启旭贸易咨询服务中心持有公司股份8,602,320股，占总股本的5.38%，股份来源于首次公开发行前取得。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500000799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688626"],"gpt_icon":0},{"id":"2603685154","title":"翔宇医疗最新公告：股东安阳启旭拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2603685154","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603685154?lang=zh_cn&edition=full","pubTime":"2026-01-13 19:40","pubTimestamp":1768304419,"startTime":"0","endTime":"0","summary":"翔宇医疗(688626.SH)公告称，股东安阳启旭贸易咨询服务中心（有限合伙）计划减持不超过480万股，占公司总股本的3%，减持方式为集中竞价和大宗交易，其中集中竞价减持不超过160万股，大宗交易减持不超过320万股。减持原因为自身资金需求，减持期间为2026年2月4日至2026年5月3日。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300036683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0},{"id":"2602335815","title":"每周股票复盘：翔宇医疗（688626）因股价涨幅登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2602335815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602335815?lang=zh_cn&edition=full","pubTime":"2026-01-11 01:25","pubTimestamp":1768065909,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，翔宇医疗报收于79.09元，较上周的60.5元上涨30.73%。本周，翔宇医疗1月7日盘中最高价报95.0元，股价触及近一年最高点。本周关注点来自交易信息汇总：翔宇医疗因日收盘价涨幅达15%及三日累计偏离值达30%登龙虎榜。来自公司公告汇总：翔宇医疗2025年前三季度归母净利润同比下降40.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774270916302,"stockEarnings":[{"period":"1week","weight":-0.2144},{"period":"1month","weight":-0.1684},{"period":"3month","weight":0.0513},{"period":"6month","weight":0.0611},{"period":"1year","weight":0.3652},{"period":"ytd","weight":-0.0615}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南翔宇医疗设备股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9531人(较上一季度增加51.24%)","perCapita":"16787股","listingDate":"2021-03-31","address":"河南省安阳市内黄县帝喾大道中段","registeredCapital":"16000万元","survey":"　　河南翔宇医疗设备股份有限公司的主营业务是康复医疗器械研发、生产、销售和服务。公司的主要产品是康复理疗设备类、康复训练设备类、康复评定设备类、经营及配件产品。作为国家级高新技术企业，翔宇医疗被国家中医药管理局认定为中医诊疗设备生产示范基地，被工信部认定为国家首批专精特新“小巨人”企业，被国家知识产权局评为国家知识产权示范企业，荣获河南省省长质量奖，翔宇医疗商标被国家工商行政管理总局评为中国驰名商标。公司是同行业率先通过ISO9001和YY/T0287idtISO13485医疗器械质量管理体系、ISO14001环境管理体系、OHSAS18001职业健康安全管理体系和知识产权管理五个体系认证的企业。报告期末，公司已获得专利1,933项，参与起草或参与评定36个国家行业标准，获得省级科技成果248项。","listedPrice":28.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翔宇医疗,688626,翔宇医疗股票,翔宇医疗股票老虎,翔宇医疗股票老虎国际,翔宇医疗行情,翔宇医疗股票行情,翔宇医疗股价,翔宇医疗股市,翔宇医疗股票价格,翔宇医疗股票交易,翔宇医疗股票购买,翔宇医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翔宇医疗(688626)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翔宇医疗(688626)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}